DERMA SCIENCES, INC.
Healthcare · Surgical & Medical Instruments & Apparatus · PA · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$22.0M | −$21.2M | −$12.6M | −$14.5M | −$3.8M | −$1.7M |
| Net income | −$10.6M | −$10.3M | −$24.0M | −$12.1M | −$4.3M | −$2.4M |
| Total assets | $114.8M | $139.3M | $88.6M | $103.8M | $58.6M | $37.0M |
| Total liabilities | $16.4M | $13.7M | $11.4M | $10.1M | $7.8M | $10.3M |
| Equity | $98.4M | $125.6M | $77.1M | $93.7M | $50.8M | $26.7M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 25.7M | 25.1M | 16.6M | 10.6M | 10.6M | 6.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- —
- Net margin
- —
- Return on equity
- −10.8%
- Return on assets
- −9.2%
- Return on capital (ROCE)
- −21.7%
- Liabilities / assets
- 14.2%
- Debt / equity
- 0.17×
- Book value / share
- $3.83
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Altman Z″ (distress)
- 4.29safe
- Accruals / assets
- 21.6%high accruals
- Piotroski F-Score
- 0/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 2 warning● 2 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- High accruals — earnings-quality risk
- Conservative leverage (liabilities < 50% of assets)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2008
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Navarro Samuel EDirector | Feb 24, 2017 | D | 37,500 | — |
| Wills Stephen TDirector | Feb 24, 2017 | D | 147,076 | — |
| Cole Robert COfficer — See Remarks | Feb 24, 2017 | D | 69,518 | — |
| Eigner FredericOfficer — Executive VP - Operations | Feb 24, 2017 | D | 49,010 | — |
| Hewlett BrettDirector | Feb 24, 2017 | D | 51,250 | — |
| Conjeevaram SriniDirector | Feb 24, 2017 | D | 81,817 | — |
| Yetter John EOfficer — EVP, Finance & CFO | Feb 24, 2017 | D | 55,983 | — |
| Moussa Robert GDirector | Feb 24, 2017 | D | 81,771 | — |
| Eigner FredericOfficer — Executive VP - Operations | Feb 10, 2017 | Option exercise | 9,375 | $6.40 |
| Yetter John EOfficer — EVP, Finance & CFO | Feb 10, 2017 | Option exercise | 9,375 | $6.40 |
| Cole Robert COfficer — See Remarks | Feb 10, 2017 | Option exercise | 9,375 | $6.40 |
| Conjeevaram SriniDirector | Feb 10, 2017 | Option exercise | 4,375 | $6.40 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsFeb 24, 2017
- Director / officer changeJan 25, 2017
- Entered a material agreement · Other material eventJan 17, 2017
- Entered a material agreement · Other material eventJan 17, 2017
- Completed an acquisition or dispositionSep 8, 2016
- Director / officer changeAug 26, 2016
- Completed an acquisition or disposition · Unregistered equity saleAug 11, 2016
- Entered a material agreement · Director / officer change · Regulation FD disclosureAug 1, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.